Cyberonics wins expanded approval for epilepsy implant.(PRODUCTS)

The US Food and Drug Administration (FDA) has approved a significant expansion of options for magnetic resonance imaging (MRI) use by patients who have the vagus nerve stimulation (VNS) implant developed by Cyberonics Inc of Houston, Texas, USA, for the treatment of epilepsy.

This approval means that patients will have access to faster, higher-resolution imaging, according to the Chief Executive of Cyberonics, Dan Moore.

The …